Literature DB >> 26939579

Variations of ATP and its metabolites in the hippocampus of rats subjected to pilocarpine-induced temporal lobe epilepsy.

Flávia Doná1,2, Isaltino Marcelo Conceição3, Henning Ulrich4, Eliane Beraldi Ribeiro5, Thalma Ariani Freitas3, Ana Leonor Abrahao Nencioni3, Maria José da Silva Fernandes6.   

Abstract

Although purinergic receptor activity has lately been associated with epilepsy, little is known about the exact role of purines in epileptogenesis. We have used a rat model of temporal lobe epilepsy induced by pilocarpine to study the dynamics of purine metabolism in the hippocampus during different times of status epilepticus (SE) and the chronic phase. Concentrations of adenosine 5'-triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), and adenosine in normal and epileptic rat hippocampus were determined by microdialysis in combination with high-performance liquid chromatography (HPLC). Extracellular ATP concentrations did not vary along 4 h of SE onset. However, AMP concentration was elevated during the second hour, whereas ADP and adenosine concentrations augmented during the third and fourth hour following SE. During chronic phase, extracellular ATP, ADP, AMP, and adenosine concentrations decreased, although these levels again increased significantly during spontaneous seizures. These results suggest that the increased turnover of ATP during the acute period is a compensatory mechanism able to reduce the excitatory role of ATP. Increased adenosine levels following 4 h of SE may contribute to block seizures. On the other hand, the reduction of purine levels in the hippocampus of chronic epileptic rats may result from metabolic changes and be part of the mechanisms involved in the onset of spontaneous seizures. This work provides further insights into purinergic signaling during establishment and chronic phase of epilepsy.

Entities:  

Keywords:  ATP metabolism; Adenosine; HPLC; Microdialysis; Temporal lobe epilepsy

Mesh:

Substances:

Year:  2016        PMID: 26939579      PMCID: PMC4854830          DOI: 10.1007/s11302-016-9504-9

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  39 in total

Review 1.  Diagnosis and treatment of temporal lobe epilepsy.

Authors:  Orrin Devinsky
Journal:  Rev Neurol Dis       Date:  2004

Review 2.  Purinergic signalling in the nervous system: an overview.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Alexei Verkhratsky; Herbert Zimmermann
Journal:  Trends Neurosci       Date:  2008-11-12       Impact factor: 13.837

Review 3.  The pilocarpine model of epilepsy.

Authors:  E A Cavalheiro
Journal:  Ital J Neurol Sci       Date:  1995 Feb-Mar

Review 4.  Purinergic signalling: from normal behaviour to pathological brain function.

Authors:  Geoffrey Burnstock; Ute Krügel; Maria P Abbracchio; Peter Illes
Journal:  Prog Neurobiol       Date:  2011-09-01       Impact factor: 11.685

Review 5.  Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.

Authors:  Robert J Delorenzo; David A Sun; Laxmikant S Deshpande
Journal:  Pharmacol Ther       Date:  2004-12-09       Impact factor: 12.310

6.  P2Y(1) receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex.

Authors:  Julia Luthardt; Sebestyen J Borvendeg; Beata Sperlagh; Wolfgang Poelchen; Kerstin Wirkner; Peter Illes
Journal:  Neurochem Int       Date:  2003-01       Impact factor: 3.921

7.  ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia.

Authors:  Alessia Melani; Daria Turchi; Maria Giuliana Vannucchi; Sara Cipriani; Marco Gianfriddo; Felicita Pedata
Journal:  Neurochem Int       Date:  2005-11       Impact factor: 3.921

8.  Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus.

Authors:  T V Dunwiddie; B B Fredholm
Journal:  J Pharmacol Exp Ther       Date:  1989-04       Impact factor: 4.030

9.  Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat.

Authors:  N Braun; Y Zhu; J Krieglstein; C Culmsee; H Zimmermann
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

10.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.

Authors:  Simon C Robson; Jean Sévigny; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

View more
  12 in total

1.  Organic washes of tissue sections for comprehensive analysis of small molecule metabolites by MALDI MS imaging of rat brain following status epilepticus.

Authors:  Hui Yang; Wenliang Ji; Ming Guan; Shilei Li; Yangyang Zhang; Zhenwen Zhao; Lanqun Mao
Journal:  Metabolomics       Date:  2018-03-14       Impact factor: 4.290

2.  Disruption of the ATP/adenosine balance in CD39-/- mice is associated with handling-induced seizures.

Authors:  Amanda J Lanser; Rafael M Rezende; Stephen Rubino; Paul J Lorello; Dustin J Donnelly; Huixin Xu; Lauren A Lau; Chris G Dulla; Barbara J Caldarone; Simon C Robson; Howard L Weiner
Journal:  Immunology       Date:  2017-08-25       Impact factor: 7.397

Review 3.  Pannexin 1 channels and ATP release in epilepsy: two sides of the same coin : The contribution of pannexin-1, connexins, and CALHM ATP-release channels to purinergic signaling.

Authors:  Elena Dossi; Nathalie Rouach
Journal:  Purinergic Signal       Date:  2021-09-08       Impact factor: 3.765

4.  Adenosine A2A receptors control synaptic remodeling in the adult brain.

Authors:  Ricardo J Rodrigues; Joana M Marques; Xinli Xu; Rui O Beleza; Francisco Q Gonçalves; Sergio Valbuena; Sofia Alçada-Morais; Nélio Gonçalves; Joana Magalhães; João M M Rocha; Sofia Ferreira; Ana S G Figueira; Juan Lerma; Rodrigo A Cunha
Journal:  Sci Rep       Date:  2022-08-29       Impact factor: 4.996

5.  The protective effect of carbenoxolone on gap junction damage in the hippocampal CA1 area of a temporal lobe epilepsy rat model.

Authors:  Yi Shu; Can Zhu; Min Zeng; Qiong Zhan; Zhiping Hu; Xiaomei Wu
Journal:  Ann Transl Med       Date:  2019-11

Review 6.  Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.

Authors:  Tobias Engel; Jonathon Smith; Mariana Alves
Journal:  J Inflamm Res       Date:  2021-07-18

Review 7.  The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy.

Authors:  Mariana Alves; Edward Beamer; Tobias Engel
Journal:  Front Pharmacol       Date:  2018-03-07       Impact factor: 5.810

8.  Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.

Authors:  Na Yue; Huijie Huang; Xiaocang Zhu; Qiuqin Han; Yalin Wang; Bing Li; Qiong Liu; Gencheng Wu; Yuqiu Zhang; Jin Yu
Journal:  J Neuroinflammation       Date:  2017-05-10       Impact factor: 8.322

Review 9.  The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy.

Authors:  Edward Beamer; Wolfgang Fischer; Tobias Engel
Journal:  Front Neurosci       Date:  2017-02-02       Impact factor: 4.677

Review 10.  Role of Adenosine in Epilepsy and Seizures.

Authors:  Fabio C Tescarollo; Diogo M Rombo; Lindsay K DeLiberto; Denise E Fedele; Enmar Alharfoush; Ângelo R Tomé; Rodrigo A Cunha; Ana M Sebastião; Detlev Boison
Journal:  J Caffeine Adenosine Res       Date:  2020-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.